We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,121 hedge funds and large institutions have $206B invested in Johnson & Johnson in 2014 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 782 increasing their positions, 910 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

304% more first-time investments, than exits

New positions opened: 206 | Existing positions closed: 51

7% more funds holding

Funds holding: 1,9882,121 (+133)

4% more capital invested

Capital invested by funds: $199B → $206B (+$7.19B)

0.1% less ownership

Funds ownership: 66.11%66.01% (-0.1%)

8% less funds holding in top 10

Funds holding in top 10: 720659 (-61)

14% less repeat investments, than reductions

Existing positions increased: 782 | Existing positions reduced: 910

34% less call options, than puts

Call options by funds: $1.66B | Put options by funds: $2.52B

Holders
2,121
Holders Change
+133
Holders Change %
+6.69%
% of All Funds
56.54%
Holding in Top 10
659
Holding in Top 10 Change
-61
Holding in Top 10 Change %
-8.47%
% of All Funds
17.57%
New
206
Increased
782
Reduced
910
Closed
51
Calls
$1.66B
Puts
$2.52B
Net Calls
-$858M
Net Calls Change
-$373M
Name Holding Trade Value Shares
Change
Change in
Stake
ACA
376
Anchor Capital Advisors
Massachusetts
$31.2M -$129K -1,220 -0.4%
VDI
377
Vaughan David Investments
Illinois
$30.9M -$643K -6,106 -2%
UB
378
UMB Bank
Missouri
$30.7M +$1.1M +10,471 +4%
GL
379
GLG LLC
New York
$30.5M -$84.7K -804 -0.3%
WG
380
Winton Group
United Kingdom
$30.4M -$42.3M -401,165 -58%
VanEck Associates
381
VanEck Associates
New York
$30.3M -$13.7M -130,125 -31%
LTFS
382
Ladenburg Thalmann Financial Services
Florida
$30M +$13.7M +130,151 +83%
DIA
383
Dana Investment Advisors
Wisconsin
$29.8M +$3.6M +34,181 +14%
CI
384
Conning Inc
Connecticut
$29.7M +$251K +2,384 +0.8%
CC
385
Cannell & Co
New York
$29.7M -$117K -1,110 -0.4%
KCM
386
Kames Capital Management
United Kingdom
$29.6M -$5.37M -51,003 -15%
JGUA
387
John G. Ullman & Associates
New York
$29.3M -$908K -8,616 -3%
SF
388
Synovus Financial
Georgia
$29.3M +$1.07M +10,145 +4%
RG
389
Rathbones Group
United Kingdom
$29.2M +$4.78M +45,349 +19%
AIM
390
Artemis Investment Management
United Kingdom
$28.8M -$5.21M -49,477 -15%
FCIM
391
Fairview Capital Investment Management
California
$28.7M -$36.9K -350 -0.1%
Northwestern Mutual Wealth Management
392
Northwestern Mutual Wealth Management
Wisconsin
$28.4M -$284K -2,694 -1%
CIBC Asset Management
393
CIBC Asset Management
Ontario, Canada
$28.1M -$8.7M -82,549 -24%
B
394
Barings
North Carolina
$28M +$3.1M +29,410 +12%
DP
395
Dearborn Partners
Illinois
$27.6M +$127K +1,201 +0.5%
CTI
396
Community Trust & Investment
Kentucky
$27.5M -$28.1K -267 -0.1%
WSFS
397
Wilmington Savings Fund Society
Delaware
$27.5M -$721K -6,837 -3%
GJIC
398
Gamble Jones Investment Counsel
California
$27.4M +$323K +3,065 +1%
BPBT
399
Boston Private Bank & Trust
Massachusetts
$27.3M -$545K -5,173 -2%
MAA
400
Matrix Asset Advisors
New York
$27.3M -$519K -4,929 -2%

JNJ Hedge Fund Activity: Q4 2014 in Review

2,121 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2014, worth a combined $206B — up 3.6% from $199B a quarter earlier.

Buyers outnumbered sellers: 206 funds opened new JNJ positions and 51 closed out — a net gain of 155 holders — while 782 added to existing stakes and 910 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $920M. The largest seller was T. Rowe Price Associates, cutting an estimated $652M.

  • 2,121 institutional investors held Johnson & Johnson (JNJ) as of Q4 2014, up from 1,988 in Q3 2014.
  • Funds reported $206B of Johnson & Johnson stock for Q4 2014, up 3.6% quarter-over-quarter.
  • 206 funds opened new Johnson & Johnson positions in Q4 2014 and 51 closed out, a net change of +155 holders.
  • The largest Johnson & Johnson buyer in Q4 2014 was Fidelity Investments, an estimated $920M added.
  • The largest Johnson & Johnson seller in Q4 2014 was T. Rowe Price Associates, an estimated $652M sold.

Based on aggregated 13F filings for Q4 2014.